The news of UBS maintaining a Neutral rating on Oracle and raising the price target from $110 to $120 indicates that the analyst sees potential for the stock price to increase, but not enough to change the overall rating. This may have a neutral impact on the stock price in the short term, as investors may view the increased price target as a positive sign, but the Neutral rating suggests that there may not be significant upside potential.